229 related articles for article (PubMed ID: 35033172)
1. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic Value of PCMT1 Expression in Gastric Cancer and Its Regulatory Effect on Spindle Assembly Checkpoints].
Wang Y; Zhang M; Zhang Z; Li B; Huang J; Li J; Geng Z; Zhang X; Song X; Wang L; Zuo L; Hu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1167-1175. PubMed ID: 38162070
[TBL] [Abstract][Full Text] [Related]
3. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.
Dong L; Li Y; Xue D; Liu Y
IUBMB Life; 2018 Apr; 70(4):291-299. PubMed ID: 29517839
[TBL] [Abstract][Full Text] [Related]
4. PCMT1 regulates the migration, invasion, and apoptosis of prostate cancer through modulating the PI3K/AKT/GSK-3β pathway.
Zhong J; Yuan C; Liu L; Du Y; Hui Y; Chen Z; Diao C; Yang R; Liu G; Liu X
Aging (Albany NY); 2023 Oct; 15(20):11654-11671. PubMed ID: 37899170
[TBL] [Abstract][Full Text] [Related]
5. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer.
Liu J; Liu B; Li Y; Mi Z; Tan H; Rong P
Eur J Med Res; 2023 Aug; 28(1):289. PubMed ID: 37596654
[TBL] [Abstract][Full Text] [Related]
6. In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells.
Zhang Z; Li F; Li Y; Li Z; Jia G
Clin Breast Cancer; 2023 Apr; 23(3):302-316. PubMed ID: 36639265
[TBL] [Abstract][Full Text] [Related]
7. PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells.
Saiding A; Maimaitiyiming D; Chen M; Yan F; Chen D; Hu X; Shi P
PeerJ; 2023; 11():e16006. PubMed ID: 37953789
[TBL] [Abstract][Full Text] [Related]
8. Protein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1.
Yan G; Qin Q; Yi B; Chuprun K; Sun H; Huang S; Sun J
Int J Cardiol; 2013 Oct; 168(4):3291-9. PubMed ID: 23647599
[TBL] [Abstract][Full Text] [Related]
9. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
10. The protective role of protein L-isoaspartyl (D-aspartate) O-methyltransferase for maintenance of mitochondrial morphology in A549 cell.
Ogasawara M; Otani M; Takano M; Shudou M; Inaba Y; Nirasawa S; Takahashi S; Kiyoi T; Tanaka Y; Kameda K; Kunugita N; Maeyama K; Sano K; Yamashita M; Yamauchi K
Exp Lung Res; 2016 Jun; 42(5):245-62. PubMed ID: 27327778
[TBL] [Abstract][Full Text] [Related]
11. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway.
Cheng X; Wang J; Liu C; Jiang T; Yang N; Liu D; Zhao H; Xu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):199. PubMed ID: 34154618
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
13. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
[TBL] [Abstract][Full Text] [Related]
14. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice.
Farrar C; Houser CR; Clarke S
Aging Cell; 2005 Feb; 4(1):1-12. PubMed ID: 15659208
[TBL] [Abstract][Full Text] [Related]
15. PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.
Guo J; Du X; Li C
Biomed Res Int; 2022; 2022():4434887. PubMed ID: 35535040
[TBL] [Abstract][Full Text] [Related]
16. Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.
Zhao Q; Qian Q; Cao D; Yang J; Gui T; Shen K
J Ovarian Res; 2018 Apr; 11(1):31. PubMed ID: 29685168
[TBL] [Abstract][Full Text] [Related]
17. The microRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: implications for apoptosis regulation.
Sambri I; Capasso R; Pucci P; Perna AF; Ingrosso D
J Biol Chem; 2011 Dec; 286(51):43690-43700. PubMed ID: 22033921
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of CGP3466B on Apoptosis Are Modulated by Protein-L-isoaspartate (D-aspartate) O-methyltransferase/Mst1 Pathways after Traumatic Brain Injury in Rats.
Liang F; Shi L; Zheng J; Chen S; Wang Y; Zhang J
Sci Rep; 2017 Aug; 7(1):9201. PubMed ID: 28835703
[TBL] [Abstract][Full Text] [Related]
20. Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D-Aspartyl) O-methyltransferase-deficient mice.
Farrar C; Clarke S
J Biol Chem; 2002 Aug; 277(31):27856-63. PubMed ID: 12023972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
